Sign in

CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
  1. 4 Open-market sale Chief Technology Officer sold 82,368 shares at an average $17.46 ($1,438,038)
  2. 4 Open-market sale Chief Medical Officer sold 55,000 shares at an average $16.50 ($907,533)
  3. 4 Open-market sale Chief Scientific Officer sold 52,115 shares at an average $16.79 ($875,042)
  4. 4 Option exercise Director acquired 1,518,373 shares (option exercise)
  5. 4 Option exercise 10% owner acquired 1,518,373 shares (option exercise)
  6. 4 Open-market buy Director bought 205,721 shares at an average $20.87 ($4,293,545)
  7. 4 Option exercise Director acquired 2,359,500 shares (option exercise)
  8. 4 Open-market buy Director bought 8,016 shares at $12.72 ($101,968)
  9. 4 Open-market buy Director bought 7,500 shares at $12.70 ($95,250)
  10. 4 Grant or award Director acquired 2,359,500 shares (grant or award)
  11. 4 Grant or award Director acquired 5,933 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Option exercise Director acquired 753,781 shares (option exercise)
  15. 4 Option exercise Director acquired 3,418,617 shares (option exercise)
  16. 4 Option exercise Director acquired 148,710.49 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Conversion 10% owner acquired 3,418,617 shares (conversion)

Page 4 of 21 · 410 filings